Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/8694
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGustianty, Elsa-
dc.contributor.authorPrahasta, Andika-
dc.contributor.authorRifada, R. Maula-
dc.contributor.authorTjokrovonco, Ludwig Melino-
dc.date.accessioned2024-12-02T03:01:12Z-
dc.date.available2024-12-02T03:01:12Z-
dc.date.issued2022-
dc.identifier.issn2338-6223-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/8694-
dc.description.abstractGlaucoma is the leading cause of irreversible blindness worldwide. Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) is a new method for treatment for refractory glaucoma with lesser complications than coventional TSCPC. This study aimed to evaluate the effectiveness and safety of MP-TSCPC (IRIDEX IQ810 Laser systems, CA) for refractory glaucoma treatment. This was a retrospective study using data obtained from the medical records of patients who underwent a MP-TSCPC procedure at Cicendo National Eye Hospital from July 2018 to September 2019. The outcomes measured were success rate (IOP decreased ≥30% from baseline with or without anti glaucoma medication at first month follow up) and post-operative complications. Fifty-seven eyes from 56 patients with a mean age of 57 years old underwent MP-TSCPC with 3 month follow up. The mean pre-operative intraocular pressure (IOP) dropped from 51.8 mmHg to 36.0 mmHg at 1 month follow up and 36.8 mmHg at the final follow up, representing an IOP decrease of 31% (1 month) and 28% (3 month). There was also a decrease of anti glaucoma medication usage from 2.51 to 2.16. The overall success rate at 1 month follow up was 49% and only 5% complication were found in this study. MP-TSCPC is safe and effective for lowering IOP and decreasing the need of anti glaucoma -medications in refractory glaucoma case. Further long-term evaluation and comparison to conventional TSCPC are still necessary.en_US
dc.language.isoen_USen_US
dc.publisherMajalah Kedokteran Bandung (MKB)en_US
dc.relation.ispartofseriesResearch Article;166-171-
dc.subjectGlaucomaen_US
dc.subjectlaseren_US
dc.subjectmicropulse transscleral cyclophotocoagulationen_US
dc.titleEfficacy and Safety of Micropulse Transscleral Cyclophotocoagulation Use in Refractory Glaucoma Patientsen_US
dc.typeArticleen_US
Appears in Collections:VOL 54 NO 3 (2022)

Files in This Item:
File Description SizeFormat 
166–171.pdf686.03 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.